In this study, twelve new hexahydropyrimidine-2,4-dione derivatives were synthesized and screened for their anticonvulsant activities. All the compounds (7a-l) which have 6 -arylhexahydropyrimidine-2,4-dione and N,N-disubstituted dithiocarbamate structures were prepared by the reaction with appropriate 3-(2-chloroethyl)-6-arylhexahydropyrimidine-2,4-diones and the corresponding N,N-disubstituted dithiocarbamate potassium salts. The structure of the synthesized compounds was confirmed by UV, IR, 1 H-NMR and elemental analysis. Their anticonvulsant activities were determined by maximal electroshock (MES), subcutaneous pentetrazol (metrazol, scMet) and roZusammenfassung torod toxicity tests for neurological deficits. According to the activity studies, 6-(4-chlorophenyl)hexahydropyrimidine-2,4-dione derivatives (7e h) were found to be highly protective against MES and scMet. Neurotoxicity was not observed in any of the tested compounds. • Antiepileptic drugs Hypnotika -Psychopharmaka -Sedativa -ZNS-Therapeutika
Introduction
Although there are a number of antiepileptic drugs available in the market, the development of more efficient compounds with less toxicity is still a requirement today for an improved antiepileptic therapy [1] . In the last decade, new anticonvulsant compounds having substantially different structures than the classical anticonvulsant drugs which contain an u reido structure have emerged [2j. In literature, 3 -substituted-6-arylhexahydropyrimidine-2,4-dione derivatives which have an ureido structure have been reported as a new group that have been found to be active in the anticonvulsant therapy [3] [4] [5] . In our previous studies, we synthesized some new 3 -alkyl-6-arylhexahydropyrimidine-2,4-dione derivatives and investigated their anticonvulsant activities [5] . At the same time, 6-arylhexahydropyrimidine-2,4-dione derivatives which have a mercapto group at 3rd position were found to be protective against scMet [4] . The results of those previous studies prompted us to synthesize several derivatives of 6 -arylhexahydropyrimidine-2,4-dione having mercapto as dithiocarbamate functional group at position 3 of the 6-arylhexahydropyrimidine-2,4-dione ring (compounds 7a-71, Scheme 1) .
In this study, potassium salts of various N,N-disubstituted dithiocarbamic acids were reacted with appropriate 3 -(2-chloroethyl)-6-arylhexahydropyrimidine-2,4-diones to obtai n a series of twelve new compounds by the same method as in our previous studies [6] . 3-(2-Chloroethyl)-6-arylhexahydropyrimidine-2,4-diones were prepared by the cyclization of thionyl chloride and the appropriate ureido acids that were synthesized in the presence of aqueous sodium hydroxide solution by reaction with an equivalent amount of 2-chloroethylisocyanate and the appropriate 3 -amino-3-arylpropanoic acids [4, 7] . 3-Amino-3-arylpropanoic acids were gained by the reaction of various arylaldehydes, malonic acid and ammonium acetate [8] [9] [10] . N,N-disubstituted di- 260 Septioglu et al. -Hexahydropyrimidine-2,4-dion derivatives thiocarbamate potassium derivatives were prepared by the reaction of the appropriate amines with CS 2 and KOH [6, 12] .
The structures of the synthesized compounds (shown in belo w) were confirmed by UV; 1R, 1 H-NMR and elemental analysis. Anticonvulsant activities of the synthesized compounds were examined by maximal electroshock (MES) and subcutaneous pentetrazole (metrazol, scMet) tests. The compounds were suspended in 30 % aqueous of PEG 400 and administered intraperitoneally in a volume of 0.01 mg/kg at body weight to the mice. Seizure assays and neurotoxicity were determined by rotorod toxicity test according to the phase I tests of the Antiepileptic Drug Development (ADD) Program which were developed by the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) [1, [13] [14] [15] .
Material and methods

Chemistry
All chemicals used in this study were purchased from Aldrich Chemical (Steinheim, Germany), Merck (Hohenbrunn, Germany) and Riedel-de Haën (Seeize, Germany). Melting points were determined on a Thomas Hoover Melting Point Apparatus (Philadelphia, PA, USA) and were uncorrected. UV spectra were recorded in methanol by an Agilent 8453 UV-Visible spectrometer (Waldbronn, Germany). IR spectra were recorded on a Perkin Elmer FT-IR spectrometer 1720 X (Uberlingen, Germany) with KBr disc (?, cm -1 ). 1 H-NMR spectra in dimethylsuIphoxide-d 6 , were obtained on a Bruker AC 80 MHz spectrophotometer (Karlsruhe, Germany) and Bruker-Spectrospin Avance DPX400 Ultra Shield NMR spectrometer (Rheinstetten, Germany). Elemental analyses were performed with a Perkin Elmer Model 240 C and Leco CHNS-932 (St. Joseph, MI, USA) at The Scientific and Technical Research Council of Turkey. The purity of the compounds was assessed by TEC on Kieselgel 60 F 254 (Merck, Darmstadt, Germany).
Twelve compounds were synthesized according to the procedures given below. 3-[3N'-(2-chloroethyl)ureido]-3-arylpropanoic acids (5a-c) were prepared as described in the literature, in the presence of aqueous sodium hydroxide solution (1N, 120 mL) by reaction with an equivalent amount ot 2-chloroethylisocyanate (0.1 mol) and the appropriate 3 -amino-3-arylpropanoic acids (4a-c) (0.1 mol) and acidified to pH = 1 with dilute hydrochloric acid. The precipitate was filtered, washed with water and dried [4, 7] .
General procedure for the preparation of 3-(2-chloroethyl)-6-arylhexahydropyrimidine-2,4-diones (6a-c)
3-(2-Chloroethyl)-6-arylhexahydropyrimidine-2,4-diones (6a-c) were prepared as in literature, by the reaction of the appropriate 3 -[3N'-(2-chloroethyl)ureido|-3-arylpropanoic acids (5a-c) (0.025 mol) with thionyl chloride (100 ml.) and evaporated to dryness. The solid residue was washed with methanol and dried [4] .
General procedure for the preparation of potassium salts of N.N-disubstituted dithiocarbamic acids (2a-d)
Potassium salts of appropriate N.N-disubstituled dithiocarbamic acids (2a-d) were prepared as described in the literature, by the reaction of the appropriate amine (la-d) (0.1 mol) with carbon disulphide (0.6 mol) and potassium hydroxyde (0.1 mol). The precipitated crude salt product was crystallized from methanol [6, 12] .
General procedure for the preparation of 2-(6-arylhexahydropyrimidine-2,4-dione-3-yl) ethyl N,N-disubstituted carbamodithioates (7a-l)
Potassium salt of appropriate N,N-disubstituted dithiocarbamic acid (2a-d) (0.002 mol) was dissolved in methanol (25 mL) with constant stirring; 3 -(2-chloroethyl)-6-arylhexahydropyrimidine-2,4-dione (6a-c) (0.002 mol) was added in portions to this solution. The mixture was heated for 3 h under reflux; the precipitate was filtered off, the solution was concentrated in vacuum and the formed precipitate was filtered and crystallized fro m methanol.
Anticonvulsant activity
Stimulator (Grass S88, Astro-Med., Grass Instrument Division, W. Warwick, RI, USA), constant current unit (Grass CCU1A, Grass Medical Instrument, Quincy, MA, USA), and corneal electrodes were used for the evaluation of anticonvulsant activity. All synthesized compounds were suspended in 30 % aqueous of PEG 400 and administered intraperitoneally in a volume of 0.01 mg/kg body weight to the mice. Twelve Swiss albino male mice (20 ± 2 g) were used for each compound (mice were obtained from the Hacettepe University Animal Farm in our laboratory according to the NINDS-ADD program [13] [14] [15] and used according to the Hacettepe University, ' Laboratory Animals Ethic Committee' 17.10.2001 date, 2001/62-6 number decision). Control animals received 30 % aqueous PEG 400. The compounds were tested for their anticonvulsant activity against MES and scMet induced seizures and the rotorod toxicity test was performed for neurological toxicity according to the phase I tests of the ADD (Antiepileptic Drug Development) programme [13] [14] [15] . Pentetrazol (metrazol) was administered s.c. on the back of the neck. The rotorod toxicity test was performed on a 1 inch diameter knurled wooden rod rotating at 6 rpm (the rotorod used in the Phas e I test was made by Hacettepe University Technical Department).
Maximal Electroshock Seizure (MES) test
Maximal electroshock seizures were elicited with a 60-cycle alternating current of 50 mA intensity (5-7 times higher than the one which is r equired to elicit minimal electroshock seizures) delivered for 0. was instilled into the eye prior to application of the electrodes in order to prevent the death of the animal. Abolition of the hind limb tonic extension component of the seizure was defined as protection.
ScMet test
85 mg/kg of pentetrazol (produces seizures in more than 95 % of mice) was administered as a 0.5 % solution subcutaneously into the posterior midline. The animal was observed lor 30 min to decide whether the failure of the threshold seizure (a single episode of clonic spasms of at least 5 s duration) could be defined as protection.
Neurotoxicity
The rotorod test was used to evaluate neurotoxicity. The animal was placed on a 1 inch diameter knurled wooden rod rotating at 6 rpm. Normal mice remain on a rod rotating at this speed indefinitely. Neurologic toxicity was defined as the failure of the animal to remain on the rod for 1 min.
Results
Chemistry
Potassium salts of various N,N-disubstituted dithiocarbamic acids (2a-d) and 3 -(2-chloroethyl)-6-arylhexahydropyrimidine-2,4-diones (6a-c) were prepared in a good yield as reported in literature [4, 6, 12] . All the targeted compounds (7a -l) were prepared by the S -alkylation method in methanol as shown in Scheme 1. Some characteristics of the compounds are given in Table 1 . The structures of the compounds were elucidated by UV, IR, 1 H-NMR and elemental analysis. The results of elemental analysis for C, H, N and S were within ± 0.4 % of the theoretical values. In IR spectra the bonds at 3400-3206, 1725-1665 and 1282-1216 cm -1 belong to NH, C=0 and C=S stretching vibrations. In 1 H-NMR spectra cyclic amines, -N-CH 2 -, -CH 2 -, -CH 2 -, S-, -CH-, aromatic and NH protons appeared at 1.30-4.05, 2.10-3.85, 2.70-3.40, 3.30-4.40, 4.50-4.85, 6.80-7.60 and 8.00-8.50 ppm, respectively. In UV spectra two transitions were seen at about 255 and 280 nm and this result agrees with literature [16] . All the spectral data of the compounds were in accordance with the assigned structures as shown below. 
2-(6-Phenylhexahydropyrimidin-2,4-dione-3-yl)ethyl morpholine-4-carbodithioate (7a)
UV
Anticonvulsant activity
The results are shown in Table 2 . According to the NINDS-ADD programme anticonvulsant activity studies, all synthesized compounds (7a-71) were found protective against M ES and/or against scMet. On the other hand, 6 -(4-chlorophenyl) derivatives (7e-7h) were found to be more active than 6 -phenyl (7a-7d) and 6 -(3-chlorophenyl) derivatives (7i-7l) among the twelve tested compounds. Neurotoxicity was not observed in any of the synthesized compounds which were administered to mice in the dose range of 30-300 mg/kg.
Discussion
Among the synthesized compounds, 2 -[6-(4-chlorophenyl) hexahydropyrimidine-2,4-dione-3-yl] ethyl 4 -phenylpiperazine-1-carbodithioate (7h) showed significantly high anticonvulsant activity in the MES and scMet tests. Therefore they seem to be promising anticonvulsant drug candidates. The synthesis studies should be continued concerning this group of compounds followed with further in vivo studies.
